Abstract Aging is the progressive loss of organ and tissue function over time
The closest pipeline candidates are orforglipron, the first non-peptide oral GLP-1 from Eli Lilly, with an FDA decision anticipated in 2026, and retatrutide, a triple GLP-1/GIP/glucagon agonist in phase 3
Dietary Improvements : GLP-1 medications help control appetite, making it easier to stick to portion-controlled meals rich in vegetables, lean proteins, and whole grains
Always check that your improvement is linked by taking it out again and seeing if you worsen again
You can get most of your B12 intake from common foods, like meat, dairy, fish, or fortified foods like bread or cereal
Eli Lilly makes dulaglutides benefits well-known, but details about possible severe medical conditions that can result from it arent as marketed